Ethan P. Foscue

This study shows that the OX1R antagonist 1-SORA-51 reduces early binge-like feeding in mice without affecting dopamine levels.

This study shows that semaglutide reduces voluntary running and alters dopamine dynamics in the nucleus accumbens of mice, independent of food intake suppression.

This study evaluates NYX-783, an NMDAR positive allosteric modulator, in mice to assess its potential to reduce opioid withdrawal symptoms and relapse.